Hereditary persistence of fetal hemoglobin [HPFH] digital illustration

Hereditary persistence of fetal hemoglobin [HPFH] Save


ICD-10 code: D56.4

Disease category: D56: Thalassemia

Understanding Hereditary Persistence of Fetal Hemoglobin (HPFH)

Hereditary Persistence of Fetal Hemoglobin (HPFH) is a rare genetic condition that affects the production of hemoglobin in the body. Hemoglobin is a protein found in red blood cells that carries oxygen from the lungs to different parts of the body. In individuals with HPFH, there is a persistence of fetal hemoglobin even after birth, which normally decreases as a person grows older.

HPFH is caused by certain genetic mutations that affect the switch from fetal hemoglobin to adult hemoglobin. Fetal hemoglobin is primarily produced during pregnancy to facilitate the transfer of oxygen from the mother to the fetus. However, in individuals with HPFH, the production of fetal hemoglobin continues into adulthood, leading to higher levels of this type of hemoglobin in their blood.

Research has shown that HPFH is generally a benign condition with no significant health consequences. This is because fetal hemoglobin has a higher affinity for oxygen compared to adult hemoglobin, which can compensate for any potential decrease in adult hemoglobin levels. The presence of higher levels of fetal hemoglobin can even be beneficial for individuals with certain blood disorders like sickle cell disease or thalassemia, as it helps to reduce the severity of their symptoms.

Although HPFH is a genetic condition, it is usually inherited in an autosomal dominant pattern. This means that if one parent carries the genetic mutation, there is a 50% chance of passing it on to their children. In some rare cases, HPFH can also be inherited in an autosomal recessive pattern.

  1. Signs and Symptoms:
    • Increased levels of fetal hemoglobin in the blood
    • No significant health consequences
    • May reduce the severity of certain blood disorders
  2. Diagnosis:
    • Genetic testing to identify the specific mutations
    • Measurement of hemoglobin levels in the blood
  3. Treatment:
    • There is no specific treatment for HPFH
    • Focus is on managing any associated blood disorders, if present

In conclusion, Hereditary Persistence of Fetal Hemoglobin (HPFH) is a rare genetic condition characterized by the persistence of fetal hemoglobin into adulthood. While it is generally a benign condition, it can have a positive impact on individuals with certain blood disorders. If you suspect you or your child may have HPFH, consult with a healthcare professional for proper diagnosis and guidance.

Treatment of Hereditary persistence of fetal hemoglobin [HPFH]:

Treatment options for Hereditary Persistence of Fetal Hemoglobin (HPFH)

Hereditary Persistence of Fetal Hemoglobin (HPFH) is a rare genetic disorder characterized by the elevated levels of fetal hemoglobin in adults. This condition affects the structure and function of red blood cells. While there is no definitive cure for HPFH, various treatment options can help manage the symptom...

To see full information about treatment please Sign up or Log in